Literature DB >> 12784117

Chronic lithium treatment inhibits pilocarpine-induced mossy fiber sprouting in rat hippocampus.

David W Cadotte1, Bin Xu, Ronald J Racine, Glenda M MacQueen, Jun Feng Wang, Bruce McEwen, L Trevor Young.   

Abstract

Lithium remains the gold standard in the treatment of bipolar disorder. Long-term treatment with lithium may lead to specific adaptational changes in gene expression that contribute to a neuroprotective effect. In this study, the pilocarpine model of spontaneous limbic epilepsy was used to induce mossy fiber sprouting (axonal growth of the dentate granule cells that synapse on the pyramidal cells of the CA3 region) to examine the prophylactic neuroprotective effects of lithium in vivo. There were four groups of animals: pilocarpine treated (Pil+/Li-); pilocarpine treated followed by lithium (Pil+/Li+); lithium alone (Pil-/Li+); control (Pil-/Li-). Timm staining was used to obtain density measurements in the stratum oriens and the inner molecular layer of the hippocampus. Mossy fiber density was higher in the pilocarpine-treated animals compared to controls. Chronic lithium following pilocarpine treatment attenuated the density of mossy fibers but lithium alone had no effect. No changes in hilar volume or neuronal number were detected using stereological procedures. The ability of lithium to attenuate activation-induced reorganization in the hippocampus provides evidence for its role as a neuroprotective agent in an in vivo model that may be relevant to its clinical effects in bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12784117     DOI: 10.1038/sj.npp.1300189

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  6 in total

1.  Stereological methods reveal the robust size and stability of ectopic hilar granule cells after pilocarpine-induced status epilepticus in the adult rat.

Authors:  Daniel P McCloskey; Tana M Hintz; Joseph P Pierce; Helen E Scharfman
Journal:  Eur J Neurosci       Date:  2006-10-17       Impact factor: 3.386

2.  Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: a longitudinal MRI study.

Authors:  Kaan Yucel; Margaret C McKinnon; Valerie H Taylor; Kathryn Macdonald; Martin Alda; L Trevor Young; Glenda M MacQueen
Journal:  Psychopharmacology (Berl)       Date:  2007-08-20       Impact factor: 4.530

3.  Effects of lithium on cortical thickness and hippocampal subfield volumes in psychotic bipolar disorder.

Authors:  C I Giakoumatos; P Nanda; I T Mathew; N Tandon; J Shah; J R Bishop; B A Clementz; G D Pearlson; J A Sweeney; C A Tamminga; M S Keshavan
Journal:  J Psychiatr Res       Date:  2014-12-23       Impact factor: 4.791

Review 4.  Lithium's role in neural plasticity and its implications for mood disorders.

Authors:  J D Gray; B S McEwen
Journal:  Acta Psychiatr Scand       Date:  2013-04-26       Impact factor: 6.392

5.  Stress-induced structural remodeling in hippocampus: prevention by lithium treatment.

Authors:  Gwendolyn E Wood; L Trevor Young; Lawrence P Reagan; Biao Chen; Bruce S McEwen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-04       Impact factor: 11.205

6.  Subcortical volumetric abnormalities in bipolar disorder.

Authors:  D P Hibar; L T Westlye; T G M van Erp; J Rasmussen; C D Leonardo; J Faskowitz; U K Haukvik; C B Hartberg; N T Doan; I Agartz; A M Dale; O Gruber; B Krämer; S Trost; B Liberg; C Abé; C J Ekman; M Ingvar; M Landén; S C Fears; N B Freimer; C E Bearden; E Sprooten; D C Glahn; G D Pearlson; L Emsell; J Kenney; C Scanlon; C McDonald; D M Cannon; J Almeida; A Versace; X Caseras; N S Lawrence; M L Phillips; D Dima; G Delvecchio; S Frangou; T D Satterthwaite; D Wolf; J Houenou; C Henry; U F Malt; E Bøen; T Elvsåshagen; A H Young; A J Lloyd; G M Goodwin; C E Mackay; C Bourne; A Bilderbeck; L Abramovic; M P Boks; N E M van Haren; R A Ophoff; R S Kahn; M Bauer; A Pfennig; M Alda; T Hajek; B Mwangi; J C Soares; T Nickson; R Dimitrova; J E Sussmann; S Hagenaars; H C Whalley; A M McIntosh; P M Thompson; O A Andreassen
Journal:  Mol Psychiatry       Date:  2016-02-09       Impact factor: 15.992

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.